Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 1421373-65-0
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
1421373-65-0 |
Appearance :: |
Yellow Solid |
Molecular Formula:: |
C28H33N7O2 |
Molecular Weight:: |
499.61 |
EINECS NO:: |
628-634-9 |
MDL NO:: |
MFCD27988062 |
CAS NO:: |
1421373-65-0 |
Appearance :: |
Yellow Solid |
Molecular Formula:: |
C28H33N7O2 |
Molecular Weight:: |
499.61 |
EINECS NO:: |
628-634-9 |
MDL NO:: |
MFCD27988062 |
Product Description:
Product Name: AZD-9291 ; Osimertinib CAS NO: 1421373-65-0
Synonyms:
2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-metho xy-5-[[4-(1-methyl-1 H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-;
Osimertinib;
N-(2-{[2-(Dimethylamino)ethyl](methyl)amino}-4-metho xy-5-{[4-(1-methyl-1 H-indol-3-yl)-2-pyrimidinyl]amino}phenyl)acrylamide;
UNII-3C06JJ0Z2O;
Mereletinib;
AZD-9291;
Chemical & Physical Properties:
Appearance : Yellow Solid.
Assay : ≥99.5%
Density:1.2g/cm3
Osimertinib (previously known as mereletinib or AZD9291; trade name Tagrisso) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug developed by AstraZeneca Pharmaceuticals – for mutated EGFR cancers.
Osimertinib (AZD-9291) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFRL858R and EGFRL858R/T790M, respectively.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
